top of page

Bifidobacterium Longum subsp. Infantis

Spore-Forming Probiotic for Digestive & Immune Health

Bifidobacterium longum subsp. infantis (commonly referred to as B. infantis) is a key early-life probiotic predominantly found in the infant gastrointestinal tract. It plays a critical role in digestive system development, immune maturation, and gut barrier integrity.


Widely used in infant nutrition, paediatric supplements, maternal wellness, and clinical nutrition products, this strain is particularly valued for its ability to utilize human milk oligosaccharides (HMOs), supporting healthy microbiota colonization in early life.

 

Parameter

Description

Microorganism

Bifidobacterium Longum subsp. infantis

Potency Range

1 Billion – 50 Billion CFU/g

Physical Form

Freeze-dried powder

Appearance

Off-white to light beige

Solubility

Good dispersibility

Shelf Life

24 months (recommended storage)

Storage Conditions

≤25 °C, cool & dry place

 

Scientifically Recognized Benefits

 

✔ Supports healthy gut microbiota development in infants

✔ Helps maintain digestive comfort and stool regularity*

✔ Contributes to immune system maturation and balance

✔ Supports intestinal barrier integrity and gut health

✔ Suitable for pediatric, maternal, and early-life wellness formulations

 


Functional Characteristics

 

  • Early colonizer of the infant gastrointestinal tract

  • Efficient metabolism of human milk oligosaccharides (HMOs)

  • Produces beneficial organic acids supporting a healthy gut environment

  • Supports gut-associated lymphoid tissue (GALT) and immune development

  • High tolerance to acidic and bile conditions, ensuring survival in the GI tract

 


Key Applications

 

  • Infant & Pediatric Nutrition (Powders, Drops, Sachets, Ready-to-Feed Products)

  • Maternal & Prenatal Nutrition

  • Digestive & Immune Health Supplements

  • Synbiotic Products (combined with HMOs, GOS, FOS)

  • Clinical Nutrition & Functional Foods

 

 

Quality, Safety & Compliance

 

✔ Manufactured in GMP & ISO-certified facilities

✔ Compliant with US FDA dietary supplement regulations

✔ Aligned with EU EFSA probiotic ingredient frameworks

✔ Suitable for GCC regulatory and import requirements

✔ Non-GMO | Gluten-free | Allergen-free

✔ Suitable for Vegetarian formulations

✔ Halal-compliant options available (for GCC markets)

 


Available documentation

 

  • Certificate of Analysis (COA)

  • Technical Data Sheet (TDS)

  • MSDS

  • Stability & Shelf-Life Studies

  • Regulatory & Origin Declarations

 


Formulation Advantages

 

  • Ideal for infant and pediatric formulations

  • Stable in single-strain and multi-strain blends

  • Compatible with prebiotics (HMOs, GOS, FOS) for synbiotic formulations

  • Performs well in powders, sachets, drops, and ready-to-feed products

  • Flexible CFU strengths for regional regulatory compliance

 


Target Market Segments

 

  • Infant & Pediatric Nutrition

  • Maternal & Prenatal Health

  • Digestive & Gut Health

  • Immune Support

  • Clinical & Functional Nutrition

 


Why Choose Our Bifidobacterium longum subsp. infantis?

 

✔ Human-origin, early-life probiotic strain

✔ Export-ready quality systems and documentation

✔ High stability and consistent CFU delivery

✔ Bulk ingredient & private-label supply options

✔ Strong technical and regulatory support

✔ Trusted for sensitive pediatric applications

 


Packaging Options

 

  • Aluminium foil laminated bags

  • Fiber drums

  • Customized bulk export packaging


Frequently Asked Questions

What are the benefits of Bifidobacterium longum subsp Infantis?

Bifidobacterium longum subsp. infantis supports healthy gut microbiota development in infants, digestive comfort and stool regularity, immune system maturation and intestinal barrier integrity. It efficiently metabolises human milk oligosaccharides (HMOs) and produces beneficial organic acids. SwissMedicare Probiotics supplies B. infantis freeze-dried powder at 1 to 50 billion CFU/g for paediatric, maternal and early-life formulations.

Bifidobacterium longum subsp. infantis (B. infantis) is a probiotic bacterium that is an early colonizer of the infant gut. It is especially efficient at using human milk oligosaccharides (HMOs) from breast milk, supporting healthy microbiota, immune maturation and gut barrier integrity. SwissMedicare offers it as an off-white to light beige freeze-dried powder with a 24-month shelf life.

Bifidobacterium longum subsp. refers to a subspecies of the species Bifidobacterium longum, where 'subsp.' is the abbreviation for subspecies. B. longum includes subsp. longum, common in adults, subsp. infantis, dominant in breastfed infants, and subsp. suis, found in animals. Subspecies share core genetics but differ in traits such as which carbohydrates they can digest.

Bifidobacterium infantis is actually a subspecies of Bifidobacterium longum, officially B. longum subsp. infantis. B. infantis specialises in digesting human milk oligosaccharides and dominates the gut of breastfed infants, while B. longum subsp. longum is more common in adults and ferments plant-derived carbohydrates. SwissMedicare supplies both ingredients for infant, adult and functional nutrition formulations.


bottom of page